Skip to content

Clinical trials

Phase 1 Recurrence trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 1 Clear all

769 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20015
20022
20033
20049
200514
200613
200713
200818
200925
201015
201126
201220
201317
201436
201530
201641
201735
201840
201953
202028
202147
202245
202355
202446
202560
202653

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed282
Recruiting139
Terminated136
Unknown status85
Active, not recruiting49
Not yet recruiting39
Withdrawn36
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene20
National Cancer Institute (NCI)19
AbbVie15
M.D. Anderson Cancer Center15
Institute of Hematology & Blood Diseases Hospital, China14
Memorial Sloan Kettering Cancer Center14
The First Affiliated Hospital with Nanjing Medical University9
Therapeutic Advances in Childhood Leukemia Consortium9
Baylor College of Medicine8
H. Lee Moffitt Cancer Center and Research Institute8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence769
Leukemia, Myeloid, Acute116
Multiple Myeloma112
Neoplasms82
Lymphoma, Non-Hodgkin79
Lymphoma78
Precursor Cell Lymphoblastic Leukemia-Lymphoma76
Neoplasm Metastasis66
Leukemia58
Leukemia, Lymphocytic, Chronic, B-Cell55

Trials

Showing 51 to 75 of 769. Each trial links to its page on Pharma Observatory.

669 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.